How much do 68Ga-, 177Lu- and 131I-based radiopharmaceuticals contribute to the global radiation exposure of nuclear medicine staff? 由 L. Struelens, E. Aalbersberg, L. Beels, N. Cherbuin, Y. D’Asseler, F. De Monte, A. Lopez Medina, M. del Carmen Riveira Martin, W. Schoonjans, C. Terwinghe, S. Van den Block, F. Vanhavere, H. Zaidi, V. Schelfhout

获取全文